BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 6796787)

  • 21. Resistance of central phenylethanolamine-n-methyl transferase containing neurons to 6-hydroxydopamine.
    Jonsson G; Fuxe K; Hökfelt T; Goldstein M
    Med Biol; 1976 Dec; 54(6):421-6. PubMed ID: 1004027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
    Jonsson G
    Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pani L; Gessa GL
    Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
    Attila LM; Ahtee L
    Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine metabolites in rat cisternal cerebrospinal fluid: major contribution from extrastriatal dopamine neurones.
    Hutson PH; Curzon G
    J Neurochem; 1986 Jan; 46(1):186-90. PubMed ID: 2415677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) increases the liberation of 3H-noradrenaline produced by depolarization of the nerve ending].
    Landa ME; Rubio MC; Jaim-Etcheverry G
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):167-80. PubMed ID: 2847491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex.
    Cohen Z; Molinatti G; Hamel E
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):894-904. PubMed ID: 9290587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam.
    Petkov VD; Grahovska T; Petkov VV; Konstantinova E; Stancheva S
    Acta Physiol Pharmacol Bulg; 1984; 10(4):6-15. PubMed ID: 6535371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of the effects of iontophoretically applied dopamine in different regions of the rat brain, with special reference to the cingulate cortex.
    Beauregard M; Ferron A; Descarries L
    Synapse; 1991 Sep; 9(1):27-34. PubMed ID: 1839089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the development of central noradrenaline neurons after neonatal axon lesions.
    Jonsson G; Sachs C
    Brain Res Bull; 1982; 9(1-6):641-50. PubMed ID: 6816391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of prolonged ethanol administration and its withdrawal on catecholamine turnover in the rat brain.
    Mazur M; Szmigielski A
    Acta Physiol Pol; 1976; 27(3):280-6. PubMed ID: 941689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM; Grzanna R
    Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus.
    Devoto P; Flore G; Saba P; Fà M; Gessa GL
    BMC Neurosci; 2005 May; 6():31. PubMed ID: 15865626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins.
    Dailly E; Chenu F; Petit-Demoulière B; Bourin M
    J Neurosci Methods; 2006 Jan; 150(1):111-5. PubMed ID: 16098600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of neurotransmitters from rat brain nerve terminals after chronic ethanol ingestion: differential effects in cortex and hippocampus.
    Sabriá J; Torres D; Pastó M; Peralba JM; Allali-Hassani A; Parés X
    Addict Biol; 2003 Sep; 8(3):287-94. PubMed ID: 13129830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Fritschy JM; Geffard M; Grzanna R
    J Chem Neuroanat; 1990; 3(4):309-21. PubMed ID: 2204356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat.
    Archer T; Jonsson G; Ross SB
    Br J Pharmacol; 1984 May; 82(1):249-57. PubMed ID: 6733355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of the neurotoxins N-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) and 6-hydroxydopamine on hypothalamic noradrenergic, dopaminergic and 5-hydroxytryptaminergic neurons in the male rat.
    Lookingland KJ; Chapin DS; McKay DW; Moore KE
    Brain Res; 1986 Feb; 365(2):228-34. PubMed ID: 2868785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.